3ggv

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:3ggv.jpg

Template:STRUCTURE 3ggv

HIV Protease, pseudo-symmetric inhibitorsHIV Protease, pseudo-symmetric inhibitors

Template:ABSTRACT PUBMED 19323562

About this StructureAbout this Structure

3GGV is a 9 chains structure of sequences from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

ReferenceReference

^{[xtra 1]}

↑ Degoey DA, Grampovnik DJ, Flentge CA, Flosi WJ, Chen HJ, Yeung CM, Randolph JT, Klein LL, Dekhtyar T, Colletti L, Marsh KC, Stoll V, Mamo M, Morfitt DC, Nguyen B, Schmidt JM, Swanson SJ, Mo H, Kati WM, Molla A, Kempf DJ. 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. J Med Chem. 2009 Apr 23;52(8):2571-86. PMID:19323562 doi:http://dx.doi.org/10.1021/jm900044w

Page seeded by OCA on Wed May 27 15:23:05 2009

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

[1] Degoey DA, Grampovnik DJ, Flentge CA, Flosi WJ, Chen HJ, Yeung CM, Randolph JT, Klein LL, Dekhtyar T, Colletti L, Marsh KC, Stoll V, Mamo M, Morfitt DC, Nguyen B, Schmidt JM, Swanson SJ, Mo H, Kati WM, Molla A, Kempf DJ. 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. J Med Chem. 2009 Apr 23;52(8):2571-86. PMID:19323562 doi:http://dx.doi.org/10.1021/jm900044w

[xtra 1]